Avid Bioservices Inc (CDMO)

[biopharm]

That's what they paid the $50K for, to present AT THE CONFERENCE. Why would people sign up to go to Australia to attend an important symposium with world leaders in lung cancer research, if the substance is going to be disclosed in advance in a PR?

Bungler, it was nice to finally see someone from Australia actually start looking in the right direction ever since that conference last year. I would think the print below and results are after months of research and hopefully it was all signs of success for Peregrine.

It was known earlier that a diverse group of white blood cells called myeloid-derived suppressor cells (MDSC) are more abundant in cancer patients than in healthy individuals.

“We have identified the monocytic cells as the important cell to target, not only in cancer but possibly for treatment of autoimmune disorders like rheumatoid arthritis or inflammatory bowel diseases where dampening the immune response could provide relief,” said Peter Murray from St Jude Children’s Research Hospital, US.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109246804